Follow
Luca Zammataro
Luca Zammataro
MD, PhD, Vice President of Translational Immunoinformatics, Kiromic Biopharma, Inc.
No verified email - Homepage
Title
Cited by
Cited by
Year
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function
G Serini, D Valdembri, S Zanivan, G Morterra, C Burkhardt, F Caccavari, ...
Nature 424 (6947), 391-397, 2003
6332003
The chemokine system in cancer biology and therapy
A Mantovani, B Savino, M Locati, L Zammataro, P Allavena, R Bonecchi
Cytokine & growth factor reviews 21 (1), 27-39, 2010
4182010
Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility
G Solinas, S Schiarea, M Liguori, M Fabbri, S Pesce, L Zammataro, ...
The Journal of Immunology 185 (1), 642-652, 2010
3752010
Differential regulation of iron homeostasis during human macrophage polarized activation
S Recalcati, M Locati, A Marini, P Santambrogio, F Zaninotto, M De Pizzol, ...
European journal of immunology 40 (3), 824-835, 2010
3592010
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
OM Pello, M De Pizzol, M Mirolo, L Soucek, L Zammataro, A Amabile, ...
Blood, The Journal of the American Society of Hematology 119 (2), 411-421, 2012
3062012
Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2
S Mitola, C Ravelli, E Moroni, V Salvi, D Leali, K Ballmer-Hofer, ...
Blood, The Journal of the American Society of Hematology 116 (18), 3677-3680, 2010
1922010
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition
S Zhao, S Bellone, S Lopez, D Thakral, C Schwab, DP English, J Black, ...
Proceedings of the National Academy of Sciences 113 (43), 12238-12243, 2016
1492016
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis
MM Mitchell, A Lleo, L Zammataro, MJ Mayo, P Invernizzi, N Bach, ...
Epigenetics 6 (1), 95-102, 2011
762011
Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase–dependent mechanism 1
S Mitola, B Brenchio, M Piccinini, L Tertoolen, L Zammataro, G Breier, ...
Circulation research 98 (1), 45-54, 2006
732006
RANK‐dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations
A Pangrazio, B Cassani, MM Guerrini, JC Crockett, V Marrella, ...
Journal of Bone and Mineral Research 27 (2), 342-351, 2012
642012
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis
C Selmi, F Cavaciocchi, A Lleo, C Cheroni, R De Francesco, SA Lombardi, ...
Frontiers in immunology 5, 128, 2014
602014
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma
C Selmi, CA Feghali-Bostwick, A Lleo, SA Lombardi, M De Santis, ...
Clinical & Experimental Immunology 169 (3), 253-262, 2012
562012
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro
S Bellone, E Bignotti, S Lonardi, F Ferrari, F Centritto, A Masserdotti, ...
Gynecologic oncology 144 (1), 146-152, 2017
502017
A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
C Han, S Bellone, ER Siegel, G Altwerger, G Menderes, E Bonazzoli, ...
Gynecologic oncology 149 (3), 585-591, 2018
462018
Exceptional response to pembrolizumab in a metastatic, chemotherapy/radiation-resistant ovarian cancer patient harboring a PD-L1-genetic rearrangement
S Bellone, N Buza, J Choi, L Zammataro, L Gay, J Elvin, DL Rimm, Y Liu, ...
Clinical Cancer Research 24 (14), 3282-3291, 2018
412018
NOTCH3 expression is linked to breast cancer seeding and distant metastasis
AA Leontovich, M Jalalirad, JL Salisbury, L Mills, C Haddox, M Schroeder, ...
Breast Cancer Research 20 (1), 1-19, 2018
392018
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
C Li, E Bonazzoli, S Bellone, J Choi, W Dong, G Menderes, G Altwerger, ...
Proceedings of the National Academy of Sciences 116 (2), 619-624, 2019
372019
SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression
G Menderes, E Bonazzoli, S Bellone, J Black, G Altwerger, A Masserdotti, ...
Gynecologic oncology 146 (1), 179-186, 2017
362017
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
L Zammataro, S Lopez, S Bellone, F Pettinella, E Bonazzoli, E Perrone, ...
Proceedings of the National Academy of Sciences 116 (45), 22730-22736, 2019
332019
Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo
E Cocco, S Lopez, J Black, S Bellone, E Bonazzoli, F Predolini, F Ferrari, ...
British Journal of Cancer, 303-311, 2016
322016
The system can't perform the operation now. Try again later.
Articles 1–20